Christian Menzer

Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial

Lisa Zimmer, Elisabeth Livingstone, Jessica C. Hassel et al. · The Lancet · 2020 · 242 citations

Medicine, Immunology, Oncology +14

Targeted Therapy in Advanced Melanoma With Rare <i>BRAF</i> Mutations

Christian Menzer, Alexander M. Menzies, Matteo S. Carlino et al. · Journal of Clinical Oncology · 2019 · 124 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial

Elisabeth Livingstone, Lisa Zimmer, Jessica C. Hassel et al. · The Lancet · 2022 · 108 citations

Medicine, Immunology, Oncology +16

Adjuvant ipilimumab compared with observation in completely resected Merkel cell carcinoma (ADMEC): A randomized, multicenter DeCOG/ADO study.

Jürgen C. Becker, Jessica C. Hassel, Christian Menzer et al. · Journal of Clinical Oncology · 2018 · 29 citations

Medicine, Oncology, Pharmacotherapy +17

Evaluation of radio-immunotherapy sequence on immunological responses and clinical outcomes in patients with melanoma brain metastases (ELEKTRA)

Jessica C. Hassel, Timo E. Schank, Heiko Smetak et al. · OncoImmunology · 2022 · 24 citations · Full text

Medicine, Immunology, Oncology +17